Leneghan Kathleen P. 4
4 · INVACARE CORP · Filed Mar 16, 2021
Insider Transaction Report
Form 4
Leneghan Kathleen P.
Interim CFO
Transactions
- Award
Common Shares
2021-03-12+33,225→ 142,215 total
Holdings
- 362.727
Phantom Stock
→ Common Shares (362.727 underlying) - 22,600
Employee Stock Option (Right to Buy)
→ Common Shares (22,600 underlying) - 4,971.025(indirect: By Invacare Retirement Savings Plan)
Common Shares
Footnotes (7)
- [F1]Restricted shares granted pursuant to the Invacare Corporation 2018 Equity Compensation Plan in an exempt transaction under Rule 16b-3. These shares vest in 1/3 annual increments over three years commencing on May 15, 2022.
- [F2]Owned by the Trustee for the Invacare Retirement Savings Plan. The information given is based on a Plan Statement of December 31, 2020, the most recent information reasonably available.
- [F3]No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4 or Form 5.
- [F4]The reporting person holds previously reported options to buy 22,600 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between September 2, 2011 and March 18, 2013, at exercise prices between $13.37 to $24.45 per share, will expire between September 2, 2021 and March 18, 2023, and became exercisable between September 30, 2012 and March 31, 2017.
- [F5]The current balance reflects the expiration of 7,200 options on August 18, 2020.
- [F6]Upon cessation of employment in accordance with the terms and conditions of the Invacare Corporation Deferred Compensation Plus Plan.
- [F7]Owned by Trustee for the Invacare Corporation Deferred Compensation Plus Plan. The information given is based on a Plan Statement of December 31, 2020, the most recent information reasonably available.